Saturday, July 11, 2026

Drug profile · INN

iothalamate sodium i-125

iothalamate sodium i-125 (GLOFIL-125) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iothalamate sodium i-125
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

iothalamate sodium i-125 (GLOFIL-125) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN iothalamate sodium i-125
Brand GLOFIL-125
Mechanism Diagnostic agent
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is iothalamate sodium i-125?

iothalamate sodium i-125 (GLOFIL-125) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for iothalamate sodium i-125?

GLOFIL-125 is a marketed brand name for iothalamate sodium i-125. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iothalamate sodium i-125?

iothalamate sodium i-125 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.